Download Contact

Physician Name:
Title:
Arafat Tfayli
Associate Professor of Clinical Medicine,
Director, Hematology/Oncology
Fellowship Program
Assistant Director for clinical operationsinpatients
Naef K. Basile Cancer Institute
Contact:
Office Location:
Clinic:
Location:
The Naef K. Basile Cancer Institute
Bldg 56, 2nd floor
Hours:
Monday: 10:00 am – 1:00 pm,
Thursday: 1:00 pm – 5:00 pm,
Friday: 2:00 pm – 5:00 pm
Scheduling Information: +961-1-350000 ext: 7485/6
Board Certification:
American Board of Internal Medicine
American Board of Medical Oncology
American Board of Hematology
The Naef K. Basile Cancer Institute
Bldg 56, 2nd floor
Email: [email protected]
Education:
Degrees
9/91 - 6/95
American University of Beirut
School of Medicine
MD Degree with Distinction
2/88 - 7/91
American University of Beirut
Biology Department
Bachelor in Science with Distinction
Training
December 2010
Winship Cancer Center- Emory University
Hands on training on management of thoracic and head and neck
malignancies.
7/01 - 6/02
Georgetown University Medical Center
Lombardi Cancer Center
Chief Fellow and Bone Marrow Transplantation Fellow
7/99 - 6/02
Georgetown University Medical Center
Lombardi Cancer Center
Hematology/Oncology Fellow
7/98 - 6/99
State University of New York at Stony Brook.
Department of Internal Medicine
Position: Chief Resident
7/95 - 6/98
State University of New York at Stony Brook.
Department of Internal Medicine.
Internal Medicine Resident
Research Interests:
Breast and lung cancer
Publications:
1- Nahleh, Z. , Tfayli, A, Najm, A, El Sayed, A, Nahle, Z. Heat shock proteins in
cancer: Targeting the 'chaperones. Future Medicinal Chemistry. 2012
May;4(7):927-935.
2- Saad Aldin E, Mourad F, Tfayli A. Gastric Antral Vascular Ectasia in a Patient
with GIST after Treatment with Imatinib: Case Report and Literature Review. Jpn
J Clin Oncol. 2012 May;42(5):447-50.
3- Farhat FS, Tfayli A, Fakhruddin N, Mahfouz R, Otrock ZK, Alameddine RS,
Awada AH, Shamseddine A. Expression, prognostic and predictive impact of
VEGF and bFGF in non-small cell lung cancer. Crit Rev Oncol Hematol. 2012
Apr 9.
4- El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A. Treatment of
metastatic breast cancer: State-of-the-art, subtypes and perspectives. Crit Rev
Oncol Hematol. 2011 Dec;80(3):433-49.
5- Tfayli A, Gadde Laxmi, Shamseddin A. Pseudonetropeunia from EDTA
leukoagglutination. Middle East Journal of Cancer 2010; 1(4): 189-190.
6- Tfayli A, Temraz S, Abou Mrad R, Shamseddine A. Breast Cancer in Low- and
Middle-Income Countries: An Emerging and Challenging Epidemic. Journal of
Oncology 2010, 2010.
7- Bose P, Dunn T, Yang J, Allen R, El-khoury C, Tfayli A. c-Kit expression and
mutations in phyllodes tumors of the breast. AntiCancer Research 30;4731-4736.
2010
8- Al-Kali A, Farooq S, Tfayli A. Tumor lysis syndrome after starting treatment
with Gleevec in a patient with chronic myelogenous leukemia. Journal of Clinical
Pharmacy and Therapeutics 34, 1–3, 2009
9- Al-Kali A, Oswal A, Tfayli A. Non-Autoimmune Hemolytic Anemia with
Clostridium Ramosum Bacteremia. Clinical Medicine- Case reports 1: 51-2. 2008
May
10- Tfayli A, Vesely S, George JN. Occurrence of Immune Thrombocytopenic
Purpura in Patients with non-hematologic Cancers: A systematic review of
Clinical Evidence from Case Reports. Community Oncology 5:260-262,2008
May.
11- Tfayli A, George J. Management of Thrombocytopenia in Patients With
Leukemia. January 2008. http://www.medscape.com/viewprogram/8636.
12- Tfayli A, Yang J, Kojouri K, Kesserwan C, Jafari M, Ozer H. Neoadjuvant
Therapy with Celecoxib to Women with Early Stage Breast Cancer. Neoplasma
55: 122 - 126, 2008.
13- Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, and Tfayli
A. Management of platinum-based chemotherapy-induced acute nausea and
vomiting: is there a superior serotonin receptor antagonist? J Oncol Pharm Pract,
13: 69-75, 2007 June.
14- Tfayli A, Holter J, Bova A, Venkatappa S, Bullock S, Dooley W, Ozer H.
Activity of combination chemotherapy, docetaxel and epirubicin as neoadjuvant
therapy for women with breast cancer. Anticancer Res.;26(6C):4911-6, 2006
Nov-Dec
15- Hamadani M. Awab A. Chaudhary L. Tfayli A. Relative efficacy of ondansetron,
granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting
associated with platinum-based chemotherapy. Journal of Oncology Pharmacy
Practice. 12(2):67-8, 2006.
16- Tfayli A, Selby G, Maqbool F, Bierbaum W, Hamadani M. Role of intra-arterial
steroid administration in the management of steroid-refractory acute
gastrointestinal graft-versus-host disease. Am J Hematol. 81(12):959-62,2006.
17- Hamadani M., Tfayli A., Sethi, S., Hamdani N. Granulocytic Sarcoma
Manifesting as Multiple Skeletal Lesions. Am J of Med Sciences. 330(3):13943,2005 Sep.
18- Ozer H., Tfayli A. Supportive Care of Cancer Patients: Hematopoietic Growth
Factors. September 2002. http://www.medscape.com/viewprogram/2029
19- Baidas S., Tfayli A., Bhargava P. Thalidomide: an old drug with new clinical
applications. Cancer Investigation 20:835-848,2002.
20- Kessler C., Tfayli A. Coagulation Disorders: congenital and acquired, in Clinical
Hematology and Oncology: Presentation, Diagnosis and Treatment, Furie B,
Cassileth P, Atkins M, Mayer R (eds). Elsevier-Churchill Livingstone,
Philadelphia, PA, 2003. pp 498-510.
21- Madajewicz S., Chowhan N., Tfayli A. et al. Therapy for patients with high grade
astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer.
88(10): 2350-2356,2000.
22- Tfayli A., Hentschel P., Madajewicz S. et al. Toxicities related to intraarterial
infusion of cisplatin and etoposide in patients with brain tumors. J. of Neurooncol.
42:73-77,1999.
23- Manzione J., Madajewicz S., Tfayli A., et al. Regional therapy of high grade
astrocytomas. Sem. In Interven. Rad. 15(4): 365-371,1998.